Skip to main content
. 2018 Oct-Dec;39(4):213–219. doi: 10.4103/ayu.AYU_147_18

Table 4.

Overall effect in Apamarga Kshara application (AKA) and group-SCL (sclerotherapy): (n=50)

Overall Result Group-AKA (n=25) Group-SCL (n=25) Total (n=50) Total %


No. of patient % No. of patient %
Complete remission 24 96% 19 76% 43 86%
Marked improvement 01 4% 03 12% 04 08%
Moderate improvement 00 0% 03 12% 03 06%
Mild improvement 00 0% 00 00% 00 00%
Unchanged 00 0% 00 0% 00 00%
Total 25 100 25 100 50 100%

AKA: Apamarga Kshara Application, SCL: Sclerotherapy